IMPORTANT SAFETY INFO The Cellfina® System is CE-marked with the intended use for long-term reduction of cellulite dimples, maintained at three years, by precise release of targeted structural tissue (fibrous septae). The most common side effects were soreness, tenderness and bruising. The Cellfina® System is only available through a licensed healthcare professional. For full product and safety information, refer to the Instructions for Use. Warnings: The safety and effectiveness of the Cellfina® System has been evaluated in the buttocks and thighs of adult females between the ages of 25 and 55, with a body mass index (BMI) between 18 and 35, and with moderate to severe cellulite dimples. Safety and effectiveness in other anatomical areas or in patients outside of these criteria has not been established. The safety and effectiveness of more than one treatment with the Cellfina® System has not been established.
Adverse events should also be reported to Merz Pharma UK Ltd by email to UKdrugsafety@merz.com or on +44 (0) 333 200 4143.